Global Naftopidil Market Growth 2025-2031

Publication ID:

LPI02256548

Publication Date:

March 3, 2025

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Naftopidil market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
United States market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Naftopidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Naftopidil players cover Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淣aftopidil Industry Forecast鈥� looks at past sales and reviews total world Naftopidil sales in 2024, providing a comprehensive analysis by region and market sector of projected Naftopidil sales for 2025 through 2031. With Naftopidil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Naftopidil industry.
This Insight Report provides a comprehensive analysis of the global Naftopidil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Naftopidil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Naftopidil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Naftopidil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Naftopidil.
This report presents a comprehensive overview, market shares, and growth opportunities of Naftopidil market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Capsule
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sinopharm Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Aurobindo Pharma
Erregierre
Jeil Pharmaceutical
Mylan Laboratories
RA Chem Pharma
Syn-Tech Chem & Pharm
Procos
Sagami Chemical Industry
Daito Pharmaceutical
Iwaki Seiyaku
Hainan Simcere Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Naftopidil market?
What factors are driving Naftopidil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Naftopidil market opportunities vary by end market size?
How does Naftopidil break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Naftopidil Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Naftopidil by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Naftopidil by Country/Region, 2020, 2024 & 2031
2.2 Naftopidil Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Naftopidil Sales by Type
2.3.1 Global Naftopidil Sales Market Share by Type (2020-2025)
2.3.2 Global Naftopidil Revenue and Market Share by Type (2020-2025)
2.3.3 Global Naftopidil Sale Price by Type (2020-2025)
2.4 Naftopidil Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Naftopidil Sales by Application
2.5.1 Global Naftopidil Sale Market Share by Application (2020-2025)
2.5.2 Global Naftopidil Revenue and Market Share by Application (2020-2025)
2.5.3 Global Naftopidil Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Naftopidil Breakdown Data by Company
3.1.1 Global Naftopidil Annual Sales by Company (2020-2025)
3.1.2 Global Naftopidil Sales Market Share by Company (2020-2025)
3.2 Global Naftopidil Annual Revenue by Company (2020-2025)
3.2.1 Global Naftopidil Revenue by Company (2020-2025)
3.2.2 Global Naftopidil Revenue Market Share by Company (2020-2025)
3.3 Global Naftopidil Sale Price by Company
3.4 Key Manufacturers Naftopidil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Naftopidil Product Location Distribution
3.4.2 Players Naftopidil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Naftopidil by Geographic Region
4.1 World Historic Naftopidil Market Size by Geographic Region (2020-2025)
4.1.1 Global Naftopidil Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Naftopidil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Naftopidil Market Size by Country/Region (2020-2025)
4.2.1 Global Naftopidil Annual Sales by Country/Region (2020-2025)
4.2.2 Global Naftopidil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Naftopidil Sales Growth
4.4 APAC Naftopidil Sales Growth
4.5 Europe Naftopidil Sales Growth
4.6 Middle East & Africa Naftopidil Sales Growth
5 Americas
5.1 Americas Naftopidil Sales by Country
5.1.1 Americas Naftopidil Sales by Country (2020-2025)
5.1.2 Americas Naftopidil Revenue by Country (2020-2025)
5.2 Americas Naftopidil Sales by Type (2020-2025)
5.3 Americas Naftopidil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Naftopidil Sales by Region
6.1.1 APAC Naftopidil Sales by Region (2020-2025)
6.1.2 APAC Naftopidil Revenue by Region (2020-2025)
6.2 APAC Naftopidil Sales by Type (2020-2025)
6.3 APAC Naftopidil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Naftopidil by Country
7.1.1 Europe Naftopidil Sales by Country (2020-2025)
7.1.2 Europe Naftopidil Revenue by Country (2020-2025)
7.2 Europe Naftopidil Sales by Type (2020-2025)
7.3 Europe Naftopidil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Naftopidil by Country
8.1.1 Middle East & Africa Naftopidil Sales by Country (2020-2025)
8.1.2 Middle East & Africa Naftopidil Revenue by Country (2020-2025)
8.2 Middle East & Africa Naftopidil Sales by Type (2020-2025)
8.3 Middle East & Africa Naftopidil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naftopidil
10.3 Manufacturing Process Analysis of Naftopidil
10.4 Industry Chain Structure of Naftopidil
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Naftopidil Distributors
11.3 Naftopidil Customer
12 World Forecast Review for Naftopidil by Geographic Region
12.1 Global Naftopidil Market Size Forecast by Region
12.1.1 Global Naftopidil Forecast by Region (2026-2031)
12.1.2 Global Naftopidil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Naftopidil Forecast by Type (2026-2031)
12.7 Global Naftopidil Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sinopharm Weiqida Pharmaceutical
13.1.1 Sinopharm Weiqida Pharmaceutical Company Information
13.1.2 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolios and Specifications
13.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sinopharm Weiqida Pharmaceutical Main Business Overview
13.1.5 Sinopharm Weiqida Pharmaceutical Latest Developments
13.2 Shanghai Shyndec Pharmaceutical
13.2.1 Shanghai Shyndec Pharmaceutical Company Information
13.2.2 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolios and Specifications
13.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.2.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Naftopidil Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Erregierre
13.4.1 Erregierre Company Information
13.4.2 Erregierre Naftopidil Product Portfolios and Specifications
13.4.3 Erregierre Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Erregierre Main Business Overview
13.4.5 Erregierre Latest Developments
13.5 Jeil Pharmaceutical
13.5.1 Jeil Pharmaceutical Company Information
13.5.2 Jeil Pharmaceutical Naftopidil Product Portfolios and Specifications
13.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jeil Pharmaceutical Main Business Overview
13.5.5 Jeil Pharmaceutical Latest Developments
13.6 Mylan Laboratories
13.6.1 Mylan Laboratories Company Information
13.6.2 Mylan Laboratories Naftopidil Product Portfolios and Specifications
13.6.3 Mylan Laboratories Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mylan Laboratories Main Business Overview
13.6.5 Mylan Laboratories Latest Developments
13.7 RA Chem Pharma
13.7.1 RA Chem Pharma Company Information
13.7.2 RA Chem Pharma Naftopidil Product Portfolios and Specifications
13.7.3 RA Chem Pharma Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 RA Chem Pharma Main Business Overview
13.7.5 RA Chem Pharma Latest Developments
13.8 Syn-Tech Chem & Pharm
13.8.1 Syn-Tech Chem & Pharm Company Information
13.8.2 Syn-Tech Chem & Pharm Naftopidil Product Portfolios and Specifications
13.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Syn-Tech Chem & Pharm Main Business Overview
13.8.5 Syn-Tech Chem & Pharm Latest Developments
13.9 Procos
13.9.1 Procos Company Information
13.9.2 Procos Naftopidil Product Portfolios and Specifications
13.9.3 Procos Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Procos Main Business Overview
13.9.5 Procos Latest Developments
13.10 Sagami Chemical Industry
13.10.1 Sagami Chemical Industry Company Information
13.10.2 Sagami Chemical Industry Naftopidil Product Portfolios and Specifications
13.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sagami Chemical Industry Main Business Overview
13.10.5 Sagami Chemical Industry Latest Developments
13.11 Daito Pharmaceutical
13.11.1 Daito Pharmaceutical Company Information
13.11.2 Daito Pharmaceutical Naftopidil Product Portfolios and Specifications
13.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Daito Pharmaceutical Main Business Overview
13.11.5 Daito Pharmaceutical Latest Developments
13.12 Iwaki Seiyaku
13.12.1 Iwaki Seiyaku Company Information
13.12.2 Iwaki Seiyaku Naftopidil Product Portfolios and Specifications
13.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Iwaki Seiyaku Main Business Overview
13.12.5 Iwaki Seiyaku Latest Developments
13.13 Hainan Simcere Pharmaceutical
13.13.1 Hainan Simcere Pharmaceutical Company Information
13.13.2 Hainan Simcere Pharmaceutical Naftopidil Product Portfolios and Specifications
13.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hainan Simcere Pharmaceutical Main Business Overview
13.13.5 Hainan Simcere Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂